Opiate Analgesic Trials and Drug Development Plans

2/1/02


Click here to start


Table of Contents

Opiate Analgesic Trials and Drug Development Plans

Patient Populations for Clinical Trials of Opioids

IMS HEALTH’s National Prescription Audit PlusTM(NPA PlusTM)

Prescriptions (in thousands) and Percent Change, Opioids*, 1996 and 2000

IMS HEALTH’s National Disease and Therapeutic IndexTM (NDTITM)

Top Indication Categories for the Opioids, Totals (Mentions, in thousands), 1996 and 2000

Sample Opioid Indications

Role of Patient Populations in Clinical Trials of Opioids

Issues in Choice of Patient Populations

Duration of Treatment in Clinical Trials

Question 1

Question 2

Author: CDER User